9,10-anthraquinone has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Abdel-Nasser, ZM; Abdeldaiem, MSI; Abdelhady, R; Alhajlah, S; AlOmeir, O; Alrouji, M; El Adle Khalaf, N; El-Bahouty, WB; El-Gharbawy, DM; Elrabat, A; Ewees, MGE; Ghaffar, DMA; Haleem, AA; Kaddah, MMY; Mohammed, OA; Saber, S; Shata, A; Zakaria, S; Zohny, MH | 1 |
| Bhandari, P; Devidas, SB; Purohit, R; Rahmatkar, SN; Sendri, N; Singh, D; Singh, R | 1 |
3 other study(ies) available for 9,10-anthraquinone and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis.
Topics: Animals; Anthraquinones; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Rats; Sulfates | 2022 |
Amelioration of cognitive deficit in zebrafish by an undescribed anthraquinone from Juglans regia L.: An in-silico, in-vitro and in-vivo approach.
Topics: Acetylcholinesterase; Acrylamide; Animals; Anthraquinones; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal; Humans; Juglans; Learning; Memory; Molecular Docking Simulation; Neuroprotective Agents; Zebrafish | 2021 |